arrow
T

Thomas Hunsaker

genentech inc
H指数:20
被引数:2,057

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Optimization of a Potent; Efficacious; and Brain-Penetrant Inhibitor of KRAS G12C

发现和优化一种强效、高效且能穿透血脑屏障的KRAS G12C抑制剂

2026-03-020
PRE
Discovery and Characterization of Divarasib (GDC-6036); a Potent Covalent Inhibitor of KRAS G12C

Divarasib (GDC-6036)的发现与表征:一种强效的KRAS G12C共价抑制剂

2026-03-020
PRE
Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Designed for the Treatment of Solid Tumors
2023-09-2916
PRE
Quantifying KRAS G12C Covalent Drug Inhibitor Activity in Mouse Tumors Using Mass Spectrometry
2023-03-064
PRE
Targeting KRAS Mutant Cancers via Combination Treatment: Discovery of a 5-Fluoro-4-(3H)-quinazolinone Aryl Urea pan-RAF Kinase Inhibitor
2021-03-2920
PRE
Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State
2018-09-0163
OAAI
GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP)
2017-09-2199
PREAI
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300
2016-09-2883
PREAI
Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development
2016-06-07128
OAAI
A Class of 2,4-Bisanilinopyrimidine Aurora A Inhibitors with Unusually High Selectivity against Aurora B
2009-04-29104
PREAI
A pentacyclic aurora kinase inhihitor (AKI-001) with high in vivo potency and oral bioavailability
2008-07-1762
PREAI